When will Novo Nordisk halve the US list price of Wegovy and Ozempic?

Novo Nordisk will halve the US list price of Wegovy and Ozempic starting in 2027.

What is the maximum percentage by which Novo Nordisk will reduce drug prices in the US?

Novo Nordisk will reduce the U.S. list prices of its drugs by up to 50%.

Which Novo Nordisk drugs will have their prices reduced in the US?

The drugs that will have their prices reduced are the blockbuster diabetes and weight-loss medications, Ozempic and Wegovy.

Home / Health / Novo Nordisk Halves Drug Prices for US Market

Novo Nordisk Halves Drug Prices for US Market

24 Feb

•

Summary

Novo Nordisk will reduce US list prices for Wegovy and Ozempic.
The price reduction for these blockbuster drugs will be up to 50%.
These changes are set to take effect starting in 2027.

Novo Nordisk Halves Drug Prices for US Market

Starting in 2027, Novo Nordisk plans to substantially decrease the U.S. list prices for its widely recognized diabetes and weight-loss drugs, Ozempic and Wegovy. The Danish pharmaceutical company stated that these price reductions could reach as high as 50%.

This significant policy change will impact two of Novo Nordisk's most successful medications. The company's decision to halve the prices of these blockbuster drugs in the American market is expected to improve patient access.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.